These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8630514)

  • 1. Body composition and energy expenditure in thyroidectomized patients during short-term hypothyroidism and thyrotropin-suppressive thyroxine therapy.
    Wolf M; Weigert A; Kreymann G
    Eur J Endocrinol; 1996 Feb; 134(2):168-73. PubMed ID: 8630514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
    Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
    Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Levothyroxine Replacement or Suppressive Therapy on Energy Expenditure and Body Composition.
    Samuels MH; Kolobova I; Smeraglio A; Peters D; Purnell JQ; Schuff KG
    Thyroid; 2016 Mar; 26(3):347-55. PubMed ID: 26700485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin concentrations of patients with sequential thyroid function changes.
    Hsieh CJ; Wang PW; Wang ST; Liu RT; Tung SC; Chien WY; Lu YC; Chen JF; Chen CH; Kuo MC
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):29-34. PubMed ID: 12100066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
    Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema.
    Karmisholt J; Andersen S; Laurberg P
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E99-103. PubMed ID: 20926526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
    Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile.
    Tagliaferri M; Berselli ME; Calò G; Minocci A; Savia G; Petroni ML; Viberti GC; Liuzzi A
    Obes Res; 2001 Mar; 9(3):196-201. PubMed ID: 11323445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Function Variation in the Normal Range, Energy Expenditure, and Body Composition in L-T4-Treated Subjects.
    Samuels MH; Kolobova I; Antosik M; Niederhausen M; Purnell JQ; Schuff KG
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2533-2542. PubMed ID: 28460140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of hormone replacement therapy following total thyroidectomy in thyroid cancer--with special reference to the analysis of thyroid hormone peripheral effects, using indirect calorimetry].
    Nozaki H; Funahashi H; Sato Y; Imai T; Oike E; Kato M; Takagi H
    Nihon Geka Gakkai Zasshi; 1991 Dec; 92(12):1700-7. PubMed ID: 1809878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Kudo T; Nishihara E; Kihara M; Ito Y; Miya A; Fukata S; Nishikawa M; Nakamura H
    Endocr J; 2019 Nov; 66(11):953-960. PubMed ID: 31270299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
    Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
    Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial Stiffness and Central Hemodynamics in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine.
    Laugesen E; Moser E; Sikjaer T; Poulsen PL; Rejnmark L
    Thyroid; 2016 Jun; 26(6):779-84. PubMed ID: 27029953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids.
    Beukhof CM; Massolt ET; Visser TJ; Korevaar TIM; Medici M; de Herder WW; Roeters van Lennep JE; Mulder MT; de Rijke YB; Reiners C; Verburg FA; Peeters RP
    Thyroid; 2018 Feb; 28(2):168-174. PubMed ID: 29316865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal.
    Lin SY; Huang SC; Sheu WH
    Metabolism; 2010 Feb; 59(2):195-9. PubMed ID: 19765779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.
    Escobar-Morreale HF; Obregón MJ; Escobar del Rey F; Morreale de Escobar G
    J Clin Invest; 1995 Dec; 96(6):2828-38. PubMed ID: 8675653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Criteria for suppressive dosage of thyroxine administered in thyroid cancer].
    Khmara IM; Demidchik IuE; Shapet'ko MN
    Vopr Onkol; 2004; 50(5):580-4. PubMed ID: 15715101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.